Cabozantinib linked to corneal perforation in patient with renal cell carcinoma
Cabozantinib is a vascular endothelial growth factor receptor tyrosine kinase inhibitor, a drug used as a therapy for several malignancies.
Related Articles
Surgeon highlights advantages of using Unity platform
LOS ANGELES — With the recently launched Unity system, Alcon aims to allow ophthalmologists to perform vitreoretinal cataract surgery and cataract surgery on the same…
Study Associates Interferon Beta with Glaucoma Risk
Patients with primary glaucoma may exhibit significantly lower levels of endogenous intraocular interferon beta (IFN-β) compared to individuals without the disease, according to a study published…
Clinical Trial Update June 2025
Access Retinal Physician’s listing of all active clinical trials in AMD, DME, RVO, and uveitis.
FDA approves prednisolone acetate ophthalmic suspension for treating steroid-responsive ocular inflammation
Prednisolone acetate ophthalmic suspension, 1% sterile references Pred Forte from Allergan.
AMD, AI, and the future of eye imaging: Inside the 2025 International SPECTRALIS Symposium
With 35+ lectures, a NASA keynote, and a river cruise through historic Heidelberg, this year’s symposium blends science and scenery
Zeteo Biomedical secures US and EU patents for drug delivery technologies
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
Visión saludable | National Eye Institute
Muchas enfermedades oculares no dan señales de advertencia. Podría tener una afección a los ojos y no saberlo. Consejos sobre cómo mantener su visión sana.
ARVO ’25: ISTH0036 in Wet AMD/DME, and New Photobiomodulation Data – Eyetube
Could addressing fibrosis in wet AMD and DME unlock greater durability of treatment? Marion Munk, MD, PhD, joins the show to discuss results from the…
Leading a Multigenerational Team
Managing generational differences in an ophthalmology practice isn’t about changing who people are—it’s about creating an environment where everyone’s strengths are valued.
For patients with aniridia, consider artificial iris implant
KIAWAH ISLAND, S.C. — Consider using an artificial iris implant in patients with congenital or acquired aniridia, Karolinne M. Rocha, MD, PhD, told Healio at…